US Broker Ratings

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Unpacking a 31% Potential Upside Amidst Revenue Challenges

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, has caught the attention of investors with a significant potential upside of 31.28% based on its average target..

Innoviva, Inc. (INVA) Stock Analysis: Eyeing a Stunning 164% Upside with a Strong Buy Rating

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology industry, is currently attracting significant attention from investors, thanks to a remarkable potential upside of 164.17%. This potential is highlighted..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 71.88% Potential Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a prominent player in the healthcare sector, is capturing investor attention with a notable potential upside of 71.88%. Specializing in wearable medical devices, the company..

Amneal Pharmaceuticals (AMRX) Investor Outlook: Analyzing 48.45% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, operates at the heart of the drug manufacturing industry, specializing in both specialty and generic pharmaceuticals. With a current..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 274.90% Upside Potential in Biotech

Biohaven Ltd. (BHVN), a pioneering entity in the healthcare sector, is capturing the attention of investors with its robust pipeline of therapies targeting diverse fields such as immunology, neuroscience, and..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Potential Upside of 108% with Strong Buy Ratings

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company specializing in innovative therapies for retinal diseases and eye conditions, has caught the eye of investors with a remarkable potential upside of..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech with Nearly 98% Revenue Growth

Ascentage Pharma Group International (AAPG), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its impressive revenue growth and innovative pipeline. Based in Suzhou,..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 53.82% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 53.82%. With a market capitalization of $3.99 billion, the..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring the 99.81% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a United Kingdom-based biotechnology company, is making waves in the healthcare sector, drawing significant attention from investors with its promising pipeline and an impressive potential..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Understanding the Healthcare Innovator’s Growth Potential

In the rapidly evolving landscape of healthcare technology, Pulse Biosciences, Inc. (NASDAQ: PLSE) stands out as a pioneering force with its innovative bioelectric medicine solutions. With a focus on the..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 28.89% Potential Upside for Investors

CONMED Corporation (NYSE: CNMD), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 28.89%. This figure is derived..

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 42% Potential Upside

Investors eyeing the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing prospect, especially given its promising 42.05% potential upside. This U.S.-based healthcare company, with a market capitalization of..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Contender with 91% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is attracting considerable attention from investors due to its significant growth potential. With a market capitalization of $1.16..

Pacira BioSciences (PCRX) Stock Analysis: Exploring a 22.88% Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, particularly within the specialty drug manufacturing industry. With a market capitalization of $1.15 billion, this Tampa-based company..

MannKind Corporation (MNKD) Stock Analysis: Unlocking a Potential 148% Upside in the Biotech Industry

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company focused on innovative therapeutic solutions for endocrine and orphan lung diseases, is capturing investor attention within the healthcare sector. With a notable potential..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising Biotech with 12.28% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is drawing considerable attention from investors, particularly due to its potential upside of 12.28%, as indicated by analysts. Operating in the highly dynamic biotechnology sector,..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A Promising 61% Potential Upside for Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotech sector with its promising therapies for rare and neurological diseases. This commercial-stage pharmaceutical company, headquartered in Plymouth Meeting,..

Envista Holdings Corp (NVST) Stock Analysis: Navigating Challenges with Strategic Positioning in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands at a crossroads in the healthcare sector, particularly within the medical instruments and supplies industry. With a current market capitalization of $3.2 billion, the..

BGM Group Ltd. (BGM): Stock Analysis Reveals Challenges Amid Revenue Decline in Healthcare Sector

BGM Group Ltd. (BGM), a player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry in China, has caught the attention of investors with its..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 34.68% Potential Upside in Healthcare Savings

GoodRx Holdings, Inc. (NASDAQ: GDRX) has carved a niche in the healthcare sector by providing a vital service: enabling consumers to save on prescription drug purchases through an innovative price..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds